Search results for: 'disease management program'

Frost & Sullivan conducted a Voice of Customer survey of 2,448 cybersecurity decision-makers and influencers in organizations with at least 250 employees in 2023 to understand their cybersecurity operations, organizational management, technology investment, threat awareness, and other factors influencing decisions for new cybersecurity investments....

This research service covers the U.S. osteoporosis market from 2004-2014. Included are disease overviews, technology trends, total market revenue forecasts, market segment revenue forecasts, and market share analysis. The market is segmented by product class: bisphosphonates, selective estrogen receptor modulators, calcitonins, parathyroid hormone...

This research is an overview of program funding and contract activity for the United States (U.S.) Department of Defense (DoD) Radar (Radio Detection and Ranging) programs and activities. Radar technology transmits radio waves which bounce off objects in their path and are used to determine the range, altitude, direction, and speed of both moving a...

The Armys Future Combat Systems (FCS) program intends to develop and field a number of new, high-tech systems designed to increase battlefield effectiveness. In 2002, the U.S. Army awarded The Boeing Company and Science Applications International Corporation (SAIC) to act as the Lead Systems Integrator (LSI) for Future Combat Systems. To overcome ...

08 Apr 2021  |  Asia Pacific  |  Market Research

Transport & Logistics Sector to Fuel Thailand’s Connected Trucks Telematics Market

Understanding Fleet Operators’ Perceptions, Switching Behaviour, and Willingness to Pay Unlocks Future Growth Potential

Infographics

×

The telematics market in Thailand has evolved over the years and gained a lot of momentum. After an increase in the number of road accidents and lives lost in commercial vehicle accidents, Thailands government enacted strict regulations for safety and operation that include telematics system installation on trucks and tractor-trucks used for transp...

29 Oct 2021  |  North America  |  Market Research

US 5G Wireless Growth Opportunities in Healthcare

Advances in Network Capabilities Liberate Remote Patient Monitoring, Telehealth, and Virtual Care from Yesterday’s Limitations

Infographics

×

5G refers to the 5th generation of wireless technology that promises to deliver game-changing benefits to users, including dramatically increased bandwidth, higher speed, reduced latency, and network slicing. The bottom line: 5G will accommodate dramatically more devices, media, and users. This will especially impact the Internet of Things, which w...

30 Apr 2020  |  Asia Pacific  |  Market Outlook

COVID-19—Implications for the Healthcare Industry, 2020

Winning Strategies and Key Opportunities that are Evolving During this Disruption

Infographics

×

A team of futurists, analysts, and consultants from the Global Transformational Health Research Team at Frost & Sullivan have come together to render a comprehensive analysis to predict the future of healthcare with COVID-19 disruption in perspective. This study provides actionable predictions and growth opportunities for major healthcare segments ...

The discovery of new drug targets for diseases with unmet medical needs has long been hindered by the complexity of processing and interpreting massive volumes of biological data. The increasing volume and veracity of clinical and research data compels the use of enabling tools and technologies, such as cloud computing, AI, machine learning, natura...

25 Apr 2022  |  North America  |  Frost Radar

Frost Radar™: Artificial Intelligence-enabled Drug Discovery, 2022

A Benchmarking System to Spark Companies to Action - Innovation that Fuels New Deal Flow and Growth Pipelines

Infographics

×

Pharmaceutical drug discovery and development has been suffering from declining success rates with new molecules primarily because of poor external validity of preclinical models and lack of efficacy of the molecule in terms of the intended disease indication. Drug success rates continue to be in the range of only 1 in 10 that enters clinical phase...